A bird's eye view of the healthcare system viewed as a continuous learning ecosystem. This suggests the need for deep collaborations and continuous sharing of insights to enable reduction of costs and improvement in outcomes
9630942363 Genuine Call Girls In Ahmedabad Gujarat Call Girls Service
Â
Towards a Continuous Learning Ecosystem: Data Innovations and Collaborations to Improve Clinical Outcomes and Reduce Cost of Care
1. Towards a Continuous Learning Ecosystem:
Data Innovations and Collaborations to Improve Clinical Outcomes and
Reduce Cost of Care
Vipul Kashyap*, Ph.D.
Cigna Healthcare
vipul.kashyap@cigna.com
April 9, 2013
Medical Informatics World, 2013, Boston, MA
* Acknowledgments â Jeff Catteau, Knowledgent (jeff.catteau@knowledgent.com)
Discussions and feedback on the Economic Decision Model
2. Outline
⢠The Healthcare Ecosystem:
â Current State ď¨ Continuous Learning Ecosystem
⢠Interactions at the Point of Care
⢠âCoordinated Healthcare Interventionâ
⢠Making it Happen: Incentivizing Research & Knowledge Sharing
â Economic Decision Model
⢠Conclusions and Next Steps
3. The Healthcare Ecosystem: Current State
Individuals Individuals
Individuals
(Populations?) (Populations?)
Hospitals
Employers Health Pharmaceutical
Advocacy Companies
Providers
Health Plans/ Clinical Research
Payors Organizations (CROs)
Employer/Payor Perspective Pharma Perspective Provider Perspective
Siloized Ecosystem â Lack of collaboration/coordination â Inefficient!
4. The Continuous Learning Ecosystem
Patient/
Individual
Lifelong Continuous Engagement
Continuous Learning
Ability to share and exchange clinical information and knowledge is a critical enabler
5. Interactions at the Point of Care
Follow Instructions:
Lab Tests, Medications, others
Medical History? Medications?
Allergies? Contraindications?
Referrals? Follow Up? Reimbursement
Continuous Learning Ecosystem: Roadblock
Does the physician have time and incentive to identify insights,
research new ideas and share them with other stakeholders?
6. Data, Analytics & Knowledge
Demographics Diagnosis Medication Procedure Allergy Contraindication Order Referral Result Reimb
Patient 1
Patient 2
Patient 3
Patient 4
Patient 5
Patient 6
Patient 7
Patient 8
Patient 9
Patient 10
Patient 11
Patient 12
Patient 13
Patient 14
Observation/Hypothesis:
Physicians implicitly leverage experience to create patterns or âCare Archetypes â
Opportunity:
Leverage âCare Archetypesâ as an organizational framework for improving cost/outcomes
Sharing and communication of âCare Archetypesâ across the Ecosystem
7. Interactions at the Point of Care: Populations
Medication/Therapy compliance
Discuss Alternatives, Activation and
Engagement
Cost Effective? Affordable?
Good Outcomes? Alternate Treatments?
Risk? Engagement/Outreach?
Behavioral Archetype? Compliance?
Incentivized?
Continuous Learning Ecosystem: Roadblock partially addressed
Transition to Pay for Performance has begun!
However: Improving Performance requires research â and sharing of insights and results
Pay for Insight/Pay for Research is not yet on the agenda!
8. Interactions at the Point of Care: Research
Comparative Effectiveness Research
Clinical Trials
Clinical Studies
New Interventions (Therapeutic, Incentives, Engagement)?
Impact of new ongoing research? Patient Participation?
Contribution of Insights:
New Cost Effective approach, Drug Side Effects, New Behavioral Incentives
Granular Care Delivery contexts where Interventions are effective?
Genomic correlates of behavioral/activation characteristics?
9. Aligning Research and Practice
Do physicians have the orientation to do research in the context of clinical practice?
Opportunity
Analysis Hypothesis
Ideation
Generation
Clinical Trials/
Populations/ Studies
Segments
Outcomes
Measurement
Differential Diagnosis/
Possible Likelihood Estimation
Diagnoses
Therapeutic
Intervention
Care
Archetypes
History Lab Tests/
& Physical Longitudinal Follow Up
Physicians continue as usual â Automated Infrastructure pulls data and performs âResearch Analyticsâ
10. Data, Analytics and Knowledge
Population Clinical Care Genome Toxicity/ Cost Risk Quality Behavioral/ Therapeutic Engagement/ Payment Patient
Dimensions* Efficacy Activation Intervention Outreach Incentives Incentives
Popltn 1
Patient 1 Interventions that need
Patient 2 to be studied/evaluated
Patient 3
Patient 4
Activation Segments
Care Archetypes
Patient Stratification
Patient 5
Populations
Popltn 2
Patient 6
Patient 7
Patient 8
Patient 9
Patient 10
Popltn 3
Patient 11
Patient 12
Patient 13
Patient 14
Alignment
Patient Care Archetypes ďł Cost/Quality Populations ďł Behavioral/Activation Segments
ďł Patient Stratification
11. Coordinated Healthcare Intervention
Therapeutic Intervention Informational
- Drugs, Procedures - Outreach
- Devices - Wellness Apps
Coordinated
Health Intervention
Motivational
Cost and Risk Sharing
- Engagement
- Provider Incentive
- Personal Incentive
⢠Optimal Health Interventions will require collaborations between stakeholders
across the ecosystem
⢠Optimizes a set of criteria:
outcomes, cost, toxicity, efficacy, utilization, economic benefit
12. Scenario: Emergence of the Third Party RO/A
Engagement Protocols
Medication
Incentives, Compliance
Infrastructure Investment Insights
Research/
Behavioral Validation
Data/Insights Licensing Model
Prescribing/
Administration Medication Adherence Licensing Model
Protocols Insights
⢠The Healthcare Ecosystem as a âContinuous Learning Systemâ â Driven by Research
⢠Reduce barriers to participation: Provide common infrastructure and a set of incentives
⢠Need to incentivize sharing data generated from on going observations and measurement
⢠Need for a trusted âThird Party Research Organization/Aggregatorâ
13. Towards an Economic Decision Model
U = R â (Ic + Ir) U = R â (Ip + Ir)
Ir consists of one time and incremental Ir consists of investments in utilization
investments: ui = ri + d â Ii and incentives
Um/2 = (Uprovider + Upayor + Upharma)
U = utility, R = Revenue Ui = U + (ri) â (Ic + Ir)
I: Investment in Care (Ic), Ir consists of investments in compliance
Research (Clinical, Utilization, Incentives) (Ir), and incentives
Payment (Ip)
⢠Utilization Model for Research drives investment in research to address the information gap
⢠Providers will rationally consume results to drive cost/outcomes improvement in clinical care
⢠Payors and Pharma will drive investments in infrastructure and incentives to drive research
⢠Optimization curve for market based on marginal gains for various components
14. Conclusions
⢠The Health Ecosystem needs to evolve into a Continuous Learning Ecosystem to achieve
cost/outcome objectives
⢠Need for Deep Collaborations & Information Sharing to close the Information Gap
Care Archetypes ďł Populations ďłActivation/Behavioral Segmentations ďł Toxicity/Efficacy
Stratifications
⢠Need to invest in infrastructure and incentivize research and knowledge sharing
â Reducing Information Gap creates value (in terms of cost/outcomes) which is consumed by
different stakeholders in the ecosystem
â Information Gap always exists (due to new knowledge and information) ď¨ new economic
incentives ď¨market evolution/continuous learning
⢠Trust â a key roadblock â may lead to the emergence of third party research
organizations/aggregators
⢠Next steps: Develop Economic Decision Model and Work on a Roadmap of Incentives to
achieve a Continuous Learning Ecosystem!